NetworkNewsWire Announces Publication Highlighting Companies Engaged in Advanced Cannabinoid Research

NEW YORK, NY–(Marketwired – Sep 29, 2017) –  NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids.

The publication, titled, “Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development,” discusses companies on a mission to find the next groundbreaking technology targeting cannabinoids. 

To view the full publication, visit:

InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) novel approach to cannabinoid biosynthesis represents a potentially more at